Inovio Biomedical to Present at Vaccine 3rd Global Congress
SAN DIEGO--(BUSINESS WIRE)--Sep. 28, 2009-- Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today it will make multiple presentations at the Vaccine 3rd Global Congress being held in Singapore October 4th ? 6th.
Inovio representatives will be making the following presentations regarding electroporation-delivered DNA vaccines:
[...]
The presentations will include progress on programs in Inovio?s pipeline. The congress program consists of invited lectures and presentations selected from submitted abstracts broadly covering vaccine development. The key objectives of the Vaccine 3rd Global Congress are to:
* provide a progressive state-of-the-art report for scientists, governmental authorities and healthcare workers
* accelerate progress in the development of vaccines
* encourage a prophylactic approach to healthcare.
http://ir.inovio.com/...rol-newsArticle&ID=1335756&highlight=